On March 31, 2022, Torii Pharmaceutical Co., Ltd. announced the Voting Results of Proposals resolved at the 130th Ordinary General Meeting of Shareholders held on March 29, 2022. The Company´s Proposals 1 to 6 were approved, and on the other hand the following proposals were rejected, the Propsoals 7 to 12 from shareholders were rejected. Specifically, the proposals are as follows: Proposal No.

1 about Appropriation of Surplus, 24 yen per share of common stock of the Company and Total amount of 674,217,480 yen. Proposal No. 2 about Partial Amendment to the Articles of Incorporation, the electronic provision system for materials for general meetings of shareholders will be implemented, Proposal No.

3 about Election of Toshio Fukuoka as Director, Proposal No. 4 about Election of Takuji Matsumura as auditor, Proposal No. 5 Election of Nobumasa Kondo Substitute Director, and Proposal No.

6 about Election of Hisashi Kumano Substitute Auditor. On the other hand, Proposal No. 7 about Partial Amendment to the Articles of Incorporation "Prohibition of Amakudari from Japan Tobacco Inc.", this article shall be newly added to the Company's Articles of Incorporation.

Proposal No. 8 about Partial Amendment to the Articles of Incorporation "Prohibition of Funding by CMS to Japan Tobacco Inc.": Chapter 7 Prohibition of Funding by CMS to Controlling Shareholders "Prohibition of Funding by CMS to Controlling Shareholders", Proposal No. 9 about Partial Amendment to the Articles of Incorporation "Experience of Directors", regarding Method of appointment: Paragraphs 1 to 3 as the current, and Paragraph 4: about Company's directors, two-thirds or more of the directors, excluding outside directors, shall have at least 10 years of practical experience in the pharmaceutical business.

Proposal No. 10 about Partial Amendment to the Articles of Incorporation "Disclosure of Capital Costs", Chapter 8 regarding Disclosure of Shareholders' Capital Cost. Proposal No about 11: Appropriation of Surplus: This Proposal shall be proposed in addition to the proposal, independent of the Company's Board of Directors, in the event that the Company's Board of Directors proposes the disposal of surplus at this Ordinary General Meeting of Shareholders.

Dividend amount per share should be 114 yen after deducting the amount of surplus dividends per share of common stock of the Company proposed by the Board of Directors to this Ordinary General Meeting of Shareholders. And Proposal No. 12 about Acquisition of Treasury Shares: Pursuant to the provisions of Article 156, Paragraph 1 of the Companies Act, within one year from the conclusion of this Ordinary General Meeting of Shareholders, the total number of common shares of the Company will be 1,968,000 shares, and the total acquisition price will be 5,614,000,000 yen.

These activist Effissimo Capital Management Pte Ltd. proposals have not been approved by the shareholder vote.